NIH Awards $470 Million to Support National Research on Long COVID
- September 17, 2021
The National Institutes of Health (NIH) awarded nearly $470 million to New York University (NYU) Langone Health under the agency’s REsearching COVID to Enhance Recovery (RECOVER) Initiative to study the long-term effects of COVID-19, the agency announced September 15.
NYU will provide grants to more than 100 researchers at over 30 institutions to support studies of why some individuals have prolonged symptoms of COVID, known as long COVID, or develop new or returning symptoms. The funding was made available under the American Rescue Plan.
“We know some people have had their lives completely upended by the major long-term effects of COVID-19,” said NIH Director Francis S. Collins, M.D., Ph.D. “These studies will aim to determine the cause and find much needed answers to prevent this often-debilitating condition and help those who suffer move toward recovery.”
Studies will include adult, pregnant, and pediatric populations and draw on data from millions of electronic health records and mobile health technologies. NIH hopes the studies can provide insights in the coming months on the incidence and prevalence of long COVID, the range of symptoms, underlying causes, risk factors, and potential strategies for treatment and prevention.